Huiheng Acquires Breast Brachytherapy System

Huiheng Medical, a company that makes radiation equipment for the treatment of cancer, has agreed to buy Portola Medical, Inc. Portola owns the global rights to manufacture and market the ClearPath™ breast brachytherapy system. Huiheng plans to market the device in China as well as the rest of the world. ClearPath has been approved for use in the US. More details... Stock Symbol: (OTCBB: HHGM)